ACO-REAL Study App

This app can only be used by participants of the ACO-REAL study.

The ACO-REAL App (access only available with a code) is your companion for participating in the ACO-REAL study by Bayer. This study investigates the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) under everyday conditions.

With the ACO-REAL App you can:
• Provide your informed consent digitally.

The ACO-REAL App enables a user-friendly and secure (EU-standard data protection) handling of key steps in your study participation – digitally available for you in one place.